These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2711964)

  • 21. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic testing in patients at high risk for sudden cardiac death. I. Nonsustained ventricular tachycardia and abnormal ventricular function.
    Spielman SR; Greenspan AM; Kay HR; Discigil KF; Webb CR; Sokoloff NM; Rae AP; Morganroth J; Horowitz LN
    J Am Coll Cardiol; 1985 Jul; 6(1):31-40. PubMed ID: 4008786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables.
    Buxton AE; Hafley GE; Lehmann MH; Gold M; O'Toole M; Tang A; Coromilas J; Hook B; Stamato NJ; Lee KL
    Circulation; 1999 Apr; 99(14):1843-50. PubMed ID: 10199881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of sustained into nonsustained ventricular tachycardia during therapy assessment by programmed ventricular stimulation: criterion for a positive drug effect?
    Schoels W; Brachmann J; Schmitt C; Waldecker B; Kuebler W
    Am J Cardiol; 1989 Aug; 64(5):329-34. PubMed ID: 2756877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease.
    Manolis AS; Estes NA
    Am J Cardiol; 1990 Jan; 65(3):201-5. PubMed ID: 2296889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in nonsustained ventricular tachycardia.
    Buxton AE; Marchlinski FE; Waxman HL; Flores BT; Cassidy DM; Josephson ME
    Am J Cardiol; 1984 May; 53(9):1275-9. PubMed ID: 6711427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia.
    Turitto G; Fontaine JM; Ursell SN; Caref EB; Henkin R; el-Sherif N
    Am J Cardiol; 1988 Jun; 61(15):1272-8. PubMed ID: 3376885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sustained ventricular tachycardia: inducibility during invasive electrophysiologic studies].
    Schlaepfer J; Fromer M; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1990 Mar; 120(13):451-5. PubMed ID: 2326615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
    Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
    Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig.
    de Langen CD; de Graeff PA; van Gilst WH; Bel KJ; Kingma JH; Wesseling H
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):186-91. PubMed ID: 2468944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.
    Pires LA; Lehmann MH; Buxton AE; Hafley GE; Lee KL;
    J Am Coll Cardiol; 2001 Oct; 38(4):1156-62. PubMed ID: 11583897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of scar and ischemia to the results of programmed electrophysiological stimulation in patients with coronary artery disease.
    Gradel C; Jain D; Batsford WP; Wackers FJ; Zaret BL
    J Nucl Cardiol; 1997; 4(5):379-86. PubMed ID: 9362014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal averaging of the surface QRS complex predicts inducibility of ventricular tachycardia in patients with syncope of unknown origin: a prospective study.
    Winters SL; Stewart D; Gomes JA
    J Am Coll Cardiol; 1987 Oct; 10(4):775-81. PubMed ID: 3655145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the characteristics of nonsustained ventricular tachycardia on Holter monitoring and sustained ventricular tachycardia observed spontaneously or induced by programmed stimulation.
    Kim SG; Mercando AD; Fisher JD
    Am J Cardiol; 1987 Aug; 60(4):288-92. PubMed ID: 3618487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of immediate versus day to day variability of ventricular tachycardia induction by programmed stimulation.
    Cooper MJ; Koo CC; Skinner MP; Mortensen PT; Hunt LJ; Richards DA; Uther JB; Ross DL
    J Am Coll Cardiol; 1989 Jun; 13(7):1599-607. PubMed ID: 2723272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.